000 | 01177 a2200349 4500 | ||
---|---|---|---|
005 | 20250513112919.0 | ||
264 | 0 | _c19970529 | |
008 | 199705s 0 0 eng d | ||
022 | _a0009-9120 | ||
024 | 7 |
_a10.1016/s0009-9120(96)00133-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYasasever, V | |
245 | 0 | 0 |
_aUtility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: special emphasis on "spiking" phenomena. _h[electronic resource] |
260 |
_bClinical biochemistry _cFeb 1997 |
||
300 |
_a53-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 |
_aBone Neoplasms _xblood |
650 | 0 | 4 |
_aBreast Neoplasms _xblood |
650 | 0 | 4 |
_aCarcinoembryonic Antigen _xblood |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMucin-1 _xblood |
700 | 1 | _aDinçer, M | |
700 | 1 | _aCamlica, H | |
700 | 1 | _aKaraloğlu, D | |
700 | 1 | _aDalay, N | |
773 | 0 |
_tClinical biochemistry _gvol. 30 _gno. 1 _gp. 53-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0009-9120(96)00133-6 _zAvailable from publisher's website |
999 |
_c9044232 _d9044232 |